Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability-Reference-Cited by-同舟云学术

Tailoring Intensity of Active Surveillance for Low-Risk Prostate Cancer Based on Individualized Prediction of Risk Stability

Published:2020-10-08 Issue:10 Volume:6 Page:e203187
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Cooperberg Matthew R.¹²,Zheng Yingye³,Faino Anna V.³,Newcomb Lisa F.⁴⁵,Zhu Kehao³,Cowan Janet E.¹,Brooks James D.⁶,Dash Atreya⁷,Gleave Martin E.⁸,Martin Frances⁹,Morgan Todd M.¹⁰,Nelson Peter S.¹¹,Thompson Ian M.¹²,Wagner Andrew A.¹³,Carroll Peter R.¹,Lin Daniel W.⁴⁵

Affiliation:

1. Helen Diller Family Comprehensive Cancer Center, Department of Urology, University of California, San Francisco

2. Department of Epidemiology & Biostatistics, University of California, San Francisco

3. Fred Hutchinson Cancer Research Center, Biostatistics Program, Public Health Sciences, Seattle, Washington

4. Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences, Seattle, Washington

5. Department of Urology, University of Washington, Seattle

6. Department of Urology, Stanford University, Stanford, California

7. Department of Urology, Veterans Affairs Puget Sound Health Care System, Seattle, Washington

8. Department of Urologic Sciences, University of British Columbia, Vancouver, Canada

9. Department of Urology, Eastern Virginia Medical School, Virginia Beach

10. Department of Urology, University of Michigan, Ann Arbor

11. Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington

12. CHRISTUS Medical Center Hospital, San Antonio, Texas

13. Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2769893/jamaoncology_cooperberg_2020_oi_200056_1619718174.39689.pdf

Reference33 articles.

1. Cancer statistics, 2020.;Siegel;CA Cancer J Clin,2020

2. Trends in management for patients with localized prostate cancer, 1990-2013.;Cooperberg;JAMA,2015

3. Practice- vs physician-level variation in use of active surveillance for men with low-risk prostate cancer: implications for collaborative quality improvement.;Auffenberg;JAMA Surg,2017

4. Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology clinical practice guideline endorsement.;Chen;J Clin Oncol,2016

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRECISE v2: An Enhanced Framework To Guide Future Research on the Use of Magnetic Resonance Imaging in Prostate Cancer Active Surveillance;European Urology;2024-09

2. Use of Decipher Prostate Biopsy Test in Patients with Favorable-risk Disease Undergoing Conservative Management or Radical Prostatectomy in the Surveillance, Epidemiology, and End Results Registry;European Urology Oncology;2024-07

3. Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry;European Urology Oncology;2024-07

4. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer;JAMA;2024-06-25

5. Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study;Cancer Medicine;2024-06